Kishor Karki1, Siddharth Saraiya2, Geoffrey D Hugo1, Nitai Mukhopadhyay3, Nuzhat Jan1, Jessica Schuster1, Matthew Schutzer1, Lester Fahrner4, Robert Groves4, Kathryn M Olsen5, John C Ford6, Elisabeth Weiss7. 1. Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia. 2. Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia; Department of Radiation Oncology, University of Toledo, Toledo, Ohio. 3. Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia. 4. Department of Radiology, Virginia Commonwealth University, Richmond, Virginia. 5. Department of Radiology, University of Colorado, Denver, Colorado. 6. Department of Radiation Oncology, University of Miami, Miami, Florida. 7. Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia. Electronic address: elisabeth.weiss@vcuhealth.org.
Abstract
PURPOSE: To investigate interobserver delineation variability for gross tumor volumes of primary lung tumors and associated pathologic lymph nodes using magnetic resonance imaging (MRI), and to compare the results with computed tomography (CT) alone- and positron emission tomography (PET)-CT-based delineations. METHODS AND MATERIALS: Seven physicians delineated the tumor volumes of 10 patients for the following scenarios: (1) CT only, (2) PET-CT fusion images registered to CT ("clinical standard"), and (3) postcontrast T1-weighted MRI registered with diffusion-weighted MRI. To compute interobserver variability, the median surface was generated from all observers' contours and used as the reference surface. A physician labeled the interface types (tumor to lung, atelectasis (collapsed lung), hilum, mediastinum, or chest wall) on the median surface. Contoured volumes and bidirectional local distances between individual observers' contours and the reference contour were analyzed. RESULTS: Computed tomography- and MRI-based tumor volumes normalized relative to PET-CT-based volumes were 1.62 ± 0.76 (mean ± standard deviation) and 1.38 ± 0.44, respectively. Volume differences between the imaging modalities were not significant. Between observers, the mean normalized volumes per patient averaged over all patients varied significantly by a factor of 1.6 (MRI) and 2.0 (CT and PET-CT) (P=4.10 × 10-5 to 3.82 × 10-9). The tumor-atelectasis interface had a significantly higher variability than other interfaces for all modalities combined (P=.0006). The interfaces with the smallest uncertainties were tumor-lung (on CT) and tumor-mediastinum (on PET-CT and MRI). CONCLUSIONS: Although MRI-based contouring showed overall larger variability than PET-CT, contouring variability depended on the interface type and was not significantly different between modalities, despite the limited observer experience with MRI. Multimodality imaging and combining different imaging characteristics might be the best approach to define the tumor volume most accurately.
PURPOSE: To investigate interobserver delineation variability for gross tumor volumes of primary lung tumors and associated pathologic lymph nodes using magnetic resonance imaging (MRI), and to compare the results with computed tomography (CT) alone- and positron emission tomography (PET)-CT-based delineations. METHODS AND MATERIALS: Seven physicians delineated the tumor volumes of 10 patients for the following scenarios: (1) CT only, (2) PET-CT fusion images registered to CT ("clinical standard"), and (3) postcontrast T1-weighted MRI registered with diffusion-weighted MRI. To compute interobserver variability, the median surface was generated from all observers' contours and used as the reference surface. A physician labeled the interface types (tumor to lung, atelectasis (collapsed lung), hilum, mediastinum, or chest wall) on the median surface. Contoured volumes and bidirectional local distances between individual observers' contours and the reference contour were analyzed. RESULTS: Computed tomography- and MRI-based tumor volumes normalized relative to PET-CT-based volumes were 1.62 ± 0.76 (mean ± standard deviation) and 1.38 ± 0.44, respectively. Volume differences between the imaging modalities were not significant. Between observers, the mean normalized volumes per patient averaged over all patients varied significantly by a factor of 1.6 (MRI) and 2.0 (CT and PET-CT) (P=4.10 × 10-5 to 3.82 × 10-9). The tumor-atelectasis interface had a significantly higher variability than other interfaces for all modalities combined (P=.0006). The interfaces with the smallest uncertainties were tumor-lung (on CT) and tumor-mediastinum (on PET-CT and MRI). CONCLUSIONS: Although MRI-based contouring showed overall larger variability than PET-CT, contouring variability depended on the interface type and was not significantly different between modalities, despite the limited observer experience with MRI. Multimodality imaging and combining different imaging characteristics might be the best approach to define the tumor volume most accurately.
Authors: R T Heelan; B E Demas; J F Caravelli; N Martini; M S Bains; P M McCormack; M Burt; D M Panicek; A Mitzner Journal: Radiology Date: 1989-03 Impact factor: 11.105
Authors: Roel J H M Steenbakkers; Joop C Duppen; Isabelle Fitton; Kirsten E I Deurloo; Lambert J Zijp; Emile F I Comans; Apollonia L J Uitterhoeve; Patrick T R Rodrigus; Gijsbert W P Kramer; Johan Bussink; Katrien De Jaeger; José S A Belderbos; Peter J C M Nowak; Marcel van Herk; Coen R N Rasch Journal: Int J Radiat Oncol Biol Phys Date: 2005-09-28 Impact factor: 7.038
Authors: Ivayla Apostolova; Rafael Wiemker; Timo Paulus; Sven Kabus; Thomas Dreilich; Jörg van den Hoff; Michail Plotkin; Janos Mester; Winfried Brenner; Ralph Buchert; Susanne Klutmann Journal: Eur Radiol Date: 2010-03-20 Impact factor: 5.315
Authors: P Giraud; D Grahek; F Montravers; M F Carette; E Deniaud-Alexandre; F Julia; J C Rosenwald; J M Cosset; J N Talbot; M Housset; E Touboul Journal: Int J Radiat Oncol Biol Phys Date: 2001-04-01 Impact factor: 7.038
Authors: Isabelle Fitton; Roel J H M Steenbakkers; Kenneth Gilhuijs; Joop C Duppen; Peter J C M Nowak; Marcel van Herk; Coen R N Rasch Journal: Int J Radiat Oncol Biol Phys Date: 2007-11-05 Impact factor: 7.038
Authors: Hannah Bainbridge; Ahmed Salem; Rob H N Tijssen; Michael Dubec; Andreas Wetscherek; Corinne Van Es; Jose Belderbos; Corinne Faivre-Finn; Fiona McDonald Journal: Transl Lung Cancer Res Date: 2017-12
Authors: Alexander John Vickers; Niluja Thiruthaneeswaran; Catherine Coyle; Prakash Manoharan; James Wylie; Lucy Kershaw; Ananya Choudhury; Alan Mcwilliam Journal: BJR Open Date: 2019-05-13